Glen Harbor Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Glen Harbor Capital Management’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$969K	Hold	2,912	–	–	0.02%	480
2019 Q2	$910K	Hold	2,912	–	–	0.02%	509
2019 Q1	$890K	Sell	2,912 -560	-16%	-$151K	0.02%	490
2018 Q4	$806K	Sell	3,472 -140	-4%	-$37.6K	0.02%	478
2018 Q3	$1.13M	Buy	3,612 +1,232	+52%	+$382K	0.02%	443
2018 Q2	$687K	Hold	2,380	–	–	0.01%	544
2018 Q1	$595K	Hold	2,380	–	–	0.01%	575
2017 Q4	$568K	Buy	2,380 +224	+10%	+$54.3K	0.01%	603
2017 Q3	$479K	Buy	2,156 +252	+13%	+$56.7K	0.01%	607
2017 Q2	$431K	Buy	1,904 +784	+70%	+$171K	0.01%	631
2017 Q1	$223K	Buy	1,120 +168	+18%	+$32.4K	0.01%	713
2016 Q4	$174K	Buy	+952	New	+$162K	﹤0.01%	725

Other funds holding BIO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Glen Harbor Capital Management's BIO Position: Q3 2019 in Review

Glen Harbor Capital Management held its Bio-Rad Laboratories Class A (BIO) position steady in Q3 2019 at 2,912 shares worth $969K. The position accounts for 0.02% of the portfolio, ranked #480.

Glen Harbor Capital Management first reported a position in BIO in Q4 2016 and has held it in 12 quarters since. The position peaked at $1.13M in Q3 2018. 355 funds tracked by Wall St. Rank hold BIO as of Q3 2019.

Glen Harbor Capital Management held 2,912 shares of Bio-Rad Laboratories Class A worth $969K as of Q3 2019.
Glen Harbor Capital Management left its Bio-Rad Laboratories Class A share count unchanged in Q3 2019.
Bio-Rad Laboratories Class A made up 0.02% of Glen Harbor Capital Management's portfolio in Q3 2019, its #480 holding.
Glen Harbor Capital Management first reported a position in Bio-Rad Laboratories Class A in Q4 2016 and has held it in 12 quarters since.
Glen Harbor Capital Management's Bio-Rad Laboratories Class A position peaked at $1.13M in Q3 2018.
355 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.